Target Name: 5-Hydroxytryptamine Receptor 2 (5-HT2)
NCBI ID: P5766
Review Report on 5-Hydroxytryptamine Receptor 2 (5-HT2) Target / Biomarker Content of Review Report on 5-Hydroxytryptamine Receptor 2 (5-HT2) Target / Biomarker
5-Hydroxytryptamine Receptor 2 (5-HT2)
Other Name(s): 5-HT2 receptor

5-HT2 Receptor: A Potential Drug Target for Psychiatric Disorders

5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) (5-HT2 receptor) is a G protein-coupled receptor that is expressed in various tissues and plays an important role in neurotransmitter signaling. It is one of the five known subtypes of the 5-hydroxytryptamine (5-HT) receptor family, which includes 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C, and 5-HT2D subtypes.

The 5-HT2 receptor is involved in the regulation of various physiological processes, including mood, anxiety, pain perception, and Reward. It is also involved in the modulation of behaviors, such as eating, masturbation, and drug use.

Recent studies have suggested that the 5-HT2 receptor may be a potential drug target in the treatment of various psychiatric and neurological disorders, such as depression, anxiety, and addiction.

One of the main reasons for the potential drug targeting of the 5-HT2 receptor is its involvement in the modulation of mood and emotion. Studies have shown that activation of the 5-HT2 receptor can induce feelings of pleasure and happiness, while inhibition of the receptor can cause feelings of boredom or disgust. This suggests that targeting the 5-HT2 receptor may be a useful way to treat symptoms of depression and anxiety.

Another potential drug target for the 5-HT2 receptor is its role in pain perception. Studies have shown that activation of the 5-HT2 receptor can increase pain sensitivity, while inhibition of the receptor has been shown to decrease pain sensitivity. This suggests that targeting the 5-HT2 receptor may be a useful way to treat chronic pain conditions.

In addition to its potential role in mood and pain perception, the 5-HT2 receptor is also involved in the regulation of sexual behavior. Studies have shown that activation of the 5-HT2 receptor can increase sexual desire, while inhibition of the receptor has been shown to decrease sexual desire. This suggests that targeting the 5-HT2 receptor may be a useful way to treat sexual disorders such as erectile dysfunction.

Another potential drug target for the 5-HT2 receptor is its role in addiction. Studies have shown that activation of the 5-HT2 receptor can increase the rewarding effects of drugs, while inhibition of the receptor has been shown to decrease the rewarding effects of drugs. This suggests that targeting the 5-HT2 receptor may be a useful way to treat addiction.

Overall, the 5-HT2 receptor is a potential drug target due to its involvement in the regulation of mood, emotion, pain perception, and sexual behavior. Future research is needed to fully understand the role of the 5-HT2 receptor in these processes and to develop effective treatments.

Protein Name: 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified Subtype)

The "5-Hydroxytryptamine Receptor 2 (5-HT2) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about 5-Hydroxytryptamine Receptor 2 (5-HT2) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

60S Ribosome | 9-1-1 cell-cycle checkpoint response complex | A-Kinase Anchor Proteins | A1BG | A1BG-AS1 | A1CF | A2M | A2M-AS1 | A2ML1 | A2MP1 | A3GALT2 | A4GALT | A4GNT | AAAS | AACS | AACSP1 | AADAC | AADACL2 | AADACL2-AS1 | AADACL3 | AADACL4 | AADACP1 | AADAT | AAGAB | AAK1 | AAMDC | AAMP | AANAT | AAR2 | AARD | AARS1 | AARS2 | AARSD1 | AASDH | AASDHPPT | AASS | AATBC | AATF | AATK | ABALON | ABAT | ABCA1 | ABCA10 | ABCA11P | ABCA12 | ABCA13 | ABCA17P | ABCA2 | ABCA3 | ABCA4 | ABCA5 | ABCA6 | ABCA7 | ABCA8 | ABCA9 | ABCB1 | ABCB10 | ABCB11 | ABCB4 | ABCB5 | ABCB6 | ABCB7 | ABCB8 | ABCB9 | ABCC1 | ABCC10 | ABCC11 | ABCC12 | ABCC13 | ABCC2 | ABCC3 | ABCC4 | ABCC5 | ABCC6 | ABCC6P1 | ABCC6P2 | ABCC8 | ABCC9 | ABCD1 | ABCD2 | ABCD3 | ABCD4 | ABCE1 | ABCF1 | ABCF1-DT | ABCF2 | ABCF3 | ABCG1 | ABCG2 | ABCG4 | ABCG5 | ABCG8 | ABHD1 | ABHD10 | ABHD11 | ABHD11-AS1 | ABHD12 | ABHD12B | ABHD13 | ABHD14A